Bass, Berry & Sims was honored to be named Law Firm of the Year for 2021 at the 20th Annual M&A Advisor Awards. M&A Advisor has been honoring excellence in dealmaking and bestowing recognition on top professionals and firms for more than two decades.
The awards were distributed at the 20th Annual M&A Advisor Awards Gala on November 17. The firm had been recognized as a finalist in a total of 19 categories for this year’s M&A Advisor Awards.
In addition to being named Law Firm of the Year, the firm was also recognized in the following two categories:
- Healthcare/Life Sciences Deal of the Year (Over $100MM)— Addus HomeCare Corporation Acquires Queen City Hospice, LLC and Affiliate Miracle City Hospice, LLC
- M&A Deal of the Year ($50MM to $75MM) — Acquisition of Healthcare Learning Innovations by Post University and Generation Partners
“These recognitions come in a year of significant M&A deal activity overplayed with several market challenges. We are thankful for the trust that our clients place in us. I commend our lawyers for the tenacity and agility they displayed over the past year,” said Kevin Douglas, chair of the firm’s Corporate & Securities Practice.
Bass, Berry & Sims continues to earn national recognition for its notable M&A capabilities, particularly in the healthcare sector. The firm’s healthcare practice is ranked the third largest by American Health Law Association (2021) and holds a nationwide ranking in Chambers USA (2016-2021); the Corporate M&A practice has been ranked #1 in Tennessee for the past nearly 20 years (2003-2021). Bass, Berry & Sims continues to climb in industry leading league tables, including being named the sixth most active in healthcare private equity deals and 20th most active U.S. private equity. (PitchBook League Tables, 2020).
About Our Corporate & Securities Practice
Public and private companies of all sizes across a variety of industries turn to Bass, Berry & Sims for counsel on a wide range of corporate matters, including mergers, acquisitions and dispositions; private equity transactions; capital markets transactions; special purpose acquisition companies (SPACs) and de-SPAC transactions; executive compensation issues; corporate governance; ESG matters; and shareholder activism. We serve as primary corporate and securities counsel to numerous public companies and have counseled on more than 150 deals ranging in size from $20 million to more than $15 billion over the past two years. Learn more here.
Our Private Equity Team has a strong reputation representing funds, lenders, investment banks, and portfolio companies in buy and sell side and growth equity transactions nationally. We have served as lead corporate counsel in hundreds of private equity-backed deals across a variety of industries. Learn more here.
About Our Healthcare Practice
Marked by an integrated approach and unmatched regulatory knowledge, the healthcare practice of Bass, Berry & Sims is a team of more than 230 experienced attorneys who leverage their diverse strengths to meet the unique demands of our clients. Our team encompasses the multitude of legal specialties necessary to service one of the largest, most highly regulated industries in the U.S. The firm has been recognized by leading healthcare and legal industry outlets, including, nationally ranked by Chambers USA for the last six years (2016-2021), recognized as the third largest healthcare law firm in the U.S. by the American Health Law Association (2021), and honored in the healthcare category as a Law360 Practice Group of the Year (2020). Read more here.
About The M&A Advisor
The M&A Advisor was founded in 1998 to offer insights and intelligence on M&A activities and has since been established as the premier global network of M&A, Turnaround and Finance professionals. To learn more visit www.maadvisor.com.